Tyra Biosciences Announces Participation at Upcoming Investor Events
Provided By PR Newswire
Last update: Aug 20, 2025
CARLSBAD, Calif., Aug. 20, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events:
Read more at prnewswire.com
